课题基金 / 基金详情

Development of new drug therapy for atherosclerosis

Development of new drug therapy for atherosclerosis
动脉粥样硬化新药治疗的开发
批准号:
06557058
负责人:
KAWATA Sumio
金额:
$4.86万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Developmental Scientific Research (B)
财政年份:
1994
资助国家:
日本
项目状态:
已结题
起止时间:
1994 至 1995

项目摘要

项目成果

KAWATA Sumio的其他基金

相似基金

相关文献

中文摘要
翻译
血管平滑肌细胞(VSMC)的迁移和增殖在动脉粥样硬化的发生发展中起着重要作用。VSMC的迁移和增殖受生长因子的刺激。Ras p21是通过生长因子受体介导的细胞内信号转导途径中的关键成分,其C端需要法尼基修饰才能发挥信号转导作用。Ras p21的这种法尼化是由法尼基:蛋白转移酶催化的。在这个项目中,我们研究了一种有效的法尼基:蛋白转移酶抑制剂甘露霉素在体外和体内对VSMC生长的抑制作用。曼努霉素在体外对VSMC增殖有抑制作用。然后,我们给颈动脉球囊损伤的大鼠注射曼纽霉素。结果,这种抑制剂显著抑制了受损颈动脉内膜的增厚。
英文摘要
Migration and proliferation of vascular smooth muscle cells (VSMC) play important roles in development of atherosclerosis. The migration and proliferation of VSMC are known to be stimulated by growth factors. Ras p21 is a key component in intracellular signal transduction pathway for cell growth via growth factor receptors.Farnesylation of C-terminal of Ras p21 is required for its function as signal transducer. This farnesylation Ras p21 is catalyzed by farnesyl : protein transferase.In this project, we examined inhibitory effects of manumycin, a potent farnesyl : protein transferase inhibitor, on VSMC growth in vitro and in vivo. Manumycin inhibited VSMC proliferation in vitro. Then, we administered manumycin to rats with balloon injury in carotid arteries. As a result, this inhibitor significantly suppressed intimal thickening in injured carotid arteries.
期刊论文(16)
专著(0)
科研奖励(0)
会议论文
H.Ishiguro,et al.: "High-performance liquid chrom,atographic assay for farnesyl:protein transferase activity with dabsylates peptide." J.Chromatogr.B. 663. 35-42 (1995)
H.Ishiguro 等人:“法呢基的高效液相色谱测定:用达磺酸盐肽进行蛋白质转移酶活性。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
K.Fukuda, S.Kawata, et al.: "Increased mitogenic response to heparin-binding epidermal growth factor-like growth facotr in vascular smooth muscle cells of diabetic rats." Arterioscr.Thromb.Vasc.Biol.15. 1680-1687 (1995)
K.Fukuda、S.Kawata 等人:“糖尿病大鼠血管平滑肌细胞中对肝素结合表皮生长因子样生长因子的促有丝分裂反应增加。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
16
    Development of liver regeneration therapy against severe hepatic failure based on stem cell science -Differentiation and growth of hepatic stem cell and cell transplantation.
    • 批准号:
      15390224
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.7万
    • 财政年份:
      2003
    • 负责人:
      KAWATA Sumio
    • 依托单位:
    Development of strategic therapy for severe hepatic failure using regenerative medicine-Isolation of hepatic stem cell expressing musashi-1 gene and cell therapy
    • 批准号:
      13470112
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $5.31万
    • 财政年份:
      2001
    • 负责人:
      KAWATA Sumio
    • 依托单位:
    Development of hepatic anti-fibrotic therapy targeted to angiotensin II receptor antagonist-soppression of collagen production in the Ito cell via TGF-β
    • 批准号:
      13557045
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $4.16万
    • 财政年份:
      2001
    • 负责人:
      KAWATA Sumio
    • 依托单位:
    Elevation of plasma TGF-b in cancer patients and study on its molecular mechanism.
    • 批准号:
      09557052
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $3.2万
    • 财政年份:
      1997
    • 负责人:
      KAWATA Sumio
    • 依托单位:
    海外基金